AstraZeneca’s lung cancer drug trial shows no significant improvement
Detailed results from one of AstraZeneca’s pivotal trials of a lung cancer drug, published on Monday, showed that the experimental precision drug had no significant impact on overall survival outcomes for patients in the trial.
POPULAR POSTS
Portugal declares risk as wildfires hit the north of the country
September 17, 2024
UK to appoint nature envoy
September 17, 2024
Death tolls rises as Central Europe floods
September 17, 2024
LIVE STREAM